ICM
EXFY icon

Invenomic Capital Management’s Expensify EXFY Stock Holding History

Invenomic Capital Management’s Portfolio EXFY Stock Details EXFY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,373,584
Closed -$4.46M – 185
2023
Q3 		$4.46M Buy
1,373,584
+9,620
+0.7% +$52K 0.19% 100
2023
Q2 		$10.9M Sell
1,363,964
-108,437
-7% -$796K 0.55% 52
2023
Q1 		$12M Buy
1,472,401
+36,043
+3% +$321K 0.68% 48
2022
Q4 		$12.7M Buy
+1,436,358
New +$16.1M 0.86% 38

Other funds holding EXFY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invenomic Capital Management's EXFY Position: Q4 2023 in Review

Invenomic Capital Management sold out of Expensify (EXFY) in Q4 2023, closing a stake of 1,373,584 shares — an estimated $4.46M sold.

Invenomic Capital Management first reported a position in EXFY in Q4 2022 and held it in 4 quarters. The position peaked at $12.7M in Q4 2022. 100 funds tracked by Wall St. Rank hold EXFY as of Q4 2023.

  • Invenomic Capital Management reported no remaining Expensify position as of Q4 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 1,373,584 Expensify shares in Q4 2023, an estimated $4.46M.
  • Invenomic Capital Management first reported a position in Expensify in Q4 2022 and held it in 4 quarters.
  • Invenomic Capital Management's Expensify position peaked at $12.7M in Q4 2022.
  • 100 funds tracked by Wall St. Rank held Expensify as of Q4 2023.

Based on Invenomic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.